Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CIPLA   MYLAN
EQUITY SHARE DATA
    CIPLA
Mar-23
MYLAN
Dec-18
CIPLA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,1853,967-   
Low Rs8522,184-   
Sales per share (Unadj.) Rs281.91,825.4-  
Earnings per share (Unadj.) Rs35.149.6-  
Cash flow per share (Unadj.) Rs49.7391.3-  
Dividends per share (Unadj.) Rs8.500-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs289.21,974.7-  
Shares outstanding (eoy) m807.15514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.61.7 214.5%   
Avg P/E ratio x29.062.0 46.7%  
P/CF ratio (eoy) x20.57.9 261.1%  
Price / Book Value ratio x3.51.6 226.1%  
Dividend payout %24.20-   
Avg Mkt Cap Rs m822,1641,582,214 52.0%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m38,3010-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m227,531939,158 24.2%  
Other income Rs m5,1210-   
Total revenues Rs m232,653939,158 24.8%   
Gross profit Rs m48,079243,019 19.8%  
Depreciation Rs m11,721175,847 6.7%   
Interest Rs m1,09545,170 2.4%   
Profit before tax Rs m40,38422,002 183.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,029-3,500 -343.6%   
Profit after tax Rs m28,35525,502 111.2%  
Gross profit margin %21.125.9 81.7%  
Effective tax rate %29.8-15.9 -187.2%   
Net profit margin %12.52.7 458.9%  
BALANCE SHEET DATA
Current assets Rs m168,051524,425 32.0%   
Current liabilities Rs m50,333382,364 13.2%   
Net working cap to sales %51.715.1 342.0%  
Current ratio x3.31.4 243.4%  
Inventory Days Days7384 87.7%  
Debtors Days Days793 7.0%  
Net fixed assets Rs m117,318182,181 64.4%   
Share capital Rs m1,614500 322.8%   
"Free" reserves Rs m231,8450-   
Net worth Rs m233,4601,015,998 23.0%   
Long term debt Rs m01,096,588 0.0%   
Total assets Rs m290,0672,725,301 10.6%  
Interest coverage x37.91.5 2,546.4%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.80.3 227.6%   
Return on assets %10.22.6 391.5%  
Return on equity %12.12.5 483.9%  
Return on capital %17.83.2 558.8%  
Exports to sales %22.60-   
Imports to sales %8.90-   
Net fx Rs m44,0800-   
CASH FLOW
From Operations Rs m32,377195,157 16.6%  
From Investments Rs m-23,885-100,875 23.7%  
From Financial Activity Rs m-9,583-90,916 10.5%  
Net Cashflow Rs m-9681,617 -59.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare CIPLA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare CIPLA With: PROCTER & GAMBLE HEALTH  AVON ORGANIC  SEQUENT SCIENTIFIC  CHEMO PHARMA  SOURCE NATURAL FOODS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.